Vitamin C & Thiamine to Treat Sepsis and Septic Shock

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Investigators propose to investigate the use of IV vitamins B1 and C in a randomized, double‐blinded, prospective trial to determine if these medications decrease mortality rates in patients with severe sepsis or septic shock. Patients experiencing evidence‐based diagnoses of sepsis and severe sepsis and septic shock will be randomized to the two study arms for care, and all other care left to decisions of intensive care teams.
Epistemonikos ID: 4757e631a6ed87165045d84e2d957019825cc287
First added on: May 21, 2024